$
Federal Contract Award
Sagent Pharmaceuticals, INC
Department of Defense · May 20, 2026 · FY2026
SPE2D326F135BSet-aside not reportedNAICS 325411
Obligated
$48
Contract details
- Award ID
- CONT_AWD_SPE2D326F135B_9700_SPE2D021D0003_9700
- PIID
- SPE2D326F135B
- Period of performance
- May 20, 2026 → May 21, 2026
- Place of performance
- SCHAUMBURG, IL, USA
- Set-aside
- Not reported
- Pricing type
- FIRM FIXED PRICE
- PSC
- 6505 — DRUGS AND BIOLOGICALS
- NAICS
- 325411 — MEDICINAL AND BOTANICAL MANUFACTURING
Scope
4571894571!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML
Parent vehicle (IDV)
Nichi-iko Pharmaceutical Co.,ltd.
UEI YDRLCQE4AJE7
This award was placed as a task/delivery order under a larger contract vehicle.
Recipient
Sagent Pharmaceuticals, INC →- UEI
- PR1HCLM3FMW7
- CAGE
- 4RP13
- Parent
- Nichi-iko Pharmaceutical Co.,ltd.
- Address
- SCHAUMBURG, IL
Awarding agency
Department of Defense →- Sub-agency
- Defense Logistics Agency
- Office
- DLA TROOP SUPPORT
- Funding agency
- Department of Defense
- Funding office
- DLA TROOP SUPPORT
See every contract Sagent Pharmaceuticals, INC has won
Full contracting history, year-over-year trends, subaward graph, and recompete alerts.
View Sagent Pharmaceuticals, INC profile →